Six deliveries per thousand are stillbirths in India, highest rate in northern states: Study
Researchers, including those from the
All India Institute of Medical Sciences
, Gorakhpur, and the Indian Council of Medical Research, New Delhi, also identified that stillbirth hotspots are located primarily in northern and central India.
Finance
Value and Valuation Masterclass - Batch 4
By CA Himanshu Jain
View Program
Artificial Intelligence
AI For Business Professionals Batch 2
By Ansh Mehra
View Program
Finance
Value and Valuation Masterclass - Batch 3
By CA Himanshu Jain
View Program
Artificial Intelligence
AI For Business Professionals
By Vaibhav Sisinity
View Program
Finance
Value and Valuation Masterclass - Batch 2
By CA Himanshu Jain
View Program
Finance
Value and Valuation Masterclass Batch-1
By CA Himanshu Jain
View Program
Chandigarh, Jammu and Kashmir, and Rajasthan in north India recorded the highest rates of stillbirth, the findings published in The Lancet Regional Health Southeast Asia journal show.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Expert Says: Market Profile is the Highly Profitable Strategy of Intraday Trading
TradeWise
Learn More
Undo
The team analysed data gathered from the fifth round of the
National Family Health Survey
(NFHS) and the 2020 report of the civil registration system, which is managed by the Ministry of Home Affairs and records vital events, including births, deaths and stillbirths across India.
"The nationwide stillbirth rate (SBR) in 2020 was 6.548 per 1,000 total births (female: 6.54; male: 6.63). Stillbirth rates were higher among urban mothers compared to rural mothers," the authors wrote.
Live Events
A higher rate of stillbirth was also found in districts where pregnant women were anaemic (deficient in iron) and underweight -- factors known to increase risk of adverse birth outcomes, including stillbirth.
Hygienic menstrual practices and caesarean (C-section) deliveries -- in which a baby is delivered through a surgical procedure -- were associated with a lower rate of stillbirth, especially in Telangana, Karnataka, and Tamil Nadu.
The results were in line with data from NFHS-5, according to which the prevalence of C-section deliveries was about 45 per cent in south India in 2019-2020, the authors said.
Evidence from states including Assam, Meghalaya, Maharashtra, Uttar Pradesh, Himachal Pradesh and Chhattisgarh showed that receiving at least four pre-delivery check-ups and adhering to iron and folic acid supplementation during pregnancy can significantly reduce the risk of stillbirth, the team said.
Overall, higher rates of stillbirths were found in regions where pregnant women were anaemic, more deliveries were occurring in public health facilities and a larger fraction of women were having a lower wealth status, they said.
However, there were no disparities in sex-specific rates of stillbirth across the country's districts, even though a higher rate of stillbirths seen among male foetuses may point to a higher biological vulnerability, the researchers said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
19 minutes ago
- Time of India
Apollo Hospitals shares in focus as brokerages hike target prices post strong Q1FY26 results
Apollo Hospitals shares are likely to be in focus on Thursday, August 14, after the company posted a strong set of Q1FY26 results , prompting multiple brokerage firms to raise their target prices for the stock. The healthcare major reported a consolidated net profit of Rs 433 crore for the quarter ended June 30, 2025, marking a 42% year-on-year increase from Rs 305 crore in the same period last year. On a sequential basis, PAT was up 11% from Rs 390 crore in Q4FY25. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Revenue from operations in Q1FY26 rose 15% year-on-year to Rs 5,842 crore compared to Rs 5,086 crore in Q1FY25. Sequentially, revenue grew 4.5% from Rs 5,592 crore in the March quarter. The robust performance was supported by growth across segments, improved specialty mix, and operational efficiency gains. Nuvama: Buy| Target price: Rs 9,010 Nuvama has raised its target price for Apollo Hospitals to Rs 9,010 from Rs 8,635, maintaining a 'Buy' rating. Live Events The brokerage noted strong performance from HealthCo and said sustained execution remains key. It expects hospital growth from H2FY26 through phased bed expansion, higher international patient inflows, and an improved specialty mix. Nuvama also highlighted potential value unlocking from the Keimed merger, front-end restructuring, and a possible listing within 18 months. HealthCo's valuation multiple was raised to 26x from 22x, and FY26E/FY27E EBITDA estimates were increased by 2% and 4%, respectively. Motilal Oswal: Buy| Target price: Rs 9,010 Motilal Oswal also raised its target price to Rs 9,010 from Rs 8,720 while maintaining a 'Buy' rating. The firm cited broad-based growth with EBITDA and PAT beating estimates on cost optimisation and noted that profitability was boosted by lower operating expenses. It highlighted a 14% year-on-year rise in surgical revenues on the back of strong CONGO therapy momentum. HealthCo is on track for cash EBITDA breakeven (excluding ESOP) by Q2FY26/Q3FY26. The brokerage expects 15%, 21%, and 28% CAGR in revenue, EBITDA, and PAT, respectively, over FY25–FY27 and has raised its FY26/FY27 earnings estimates by 7%. Avendus: Buy| Target price: Rs 8,765 Avendus has increased its target price for Apollo Hospitals to Rs 8,765 from Rs 8,515, reiterating a 'Buy' call. The brokerage has advanced the breakeven timeline for the online business EBITDA to FY27 from FY28 earlier. It projects ex-Keimed revenue CAGR at 17% in FY25–FY27, with EBITDA expected at Rs 510 crore and Rs 770 crore for FY26 and FY27, respectively. Offline pharmacy revenue CAGR is also projected at 17%, while existing units' EBITDA CAGR is estimated at 16% in the same period. Avendus factors in the AHCo–Keimed merger in April 2026 and the APL front-end acquisition in April 2027. It expects healthcare services EBITDA CAGR of 14% and AHLL at 22% over FY25–FY27. FY26/FY27 EBITDA estimates have been raised by 4% each, driven by higher AHCo EBITDA, partly offset by new hospital losses. Also read: Zerodha's Nithin Kamath on how a boring, invisible Sebi step brought windfall gains for retail investors ( Disclaimer : Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)
Time of India
27 minutes ago
- Time of India
Vece Paes, Olympic bronze medallist, father of Leander Paes, passes away
Vece Paes (L) and son Leander Paes (R) both won medals at the Summer Olympics. (Image: X) Dr. Vece Paes, an Olympic hockey bronze medalist and pioneering sports medicine expert, passed away on Thursday at the age of 80. Born in Goa in April 1945, Dr. Paes achieved distinction in both sports and medicine, most notably as a midfielder in the Indian hockey team that won bronze at the 1972 Munich Olympics, while later establishing himself as a prominent figure in sports medicine and administration. Dr. Paes demonstrated exceptional versatility in athletics throughout his career, participating in multiple sports at competitive levels. Beyond his Olympic achievement in hockey, he competed in divisional cricket, football, and rugby, showcasing his broad athletic capabilities. His connection to rugby extended beyond playing, as he served as the president of the Indian Rugby Football Union for six years, from 1996 to 2002, contributing to the sport's development in India. After pursuing his medical education in Kolkata, Dr. Paes successfully merged his medical expertise with his passion for sports. This unique combination led to significant contributions in sports medicine, particularly in the realm of anti-doping education. His professional involvement with major sporting organisations included work with the Asian Cricket Council and the Board of Control for Cricket in India (BCCI). by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Drive, Sail & Save – The Budget-Friendly Way to Explore Europe! Learn More Undo In these roles, he managed anti-doping education programmes, establishing himself as a respected authority in sports medicine. Dr. Paes's medical background and sports experience positioned him uniquely to understand and address the health challenges faced by athletes. His work in sports medicine earned widespread recognition and helped establish new standards in athletic healthcare and anti-doping practices in India. Catch Rani Rampal's inspiring story on Game On, Episode 4. Watch Here!
Time of India
36 minutes ago
- Time of India
Dangerous virus on the prowl? Scientists investigate Colorado rabbits with tentacles after alarming mutation fears
Colorado wildlife officials are urging calm after a spate of unusual sightings, rabbits with dark, horn-like growths sprouting from their heads and faces, has stirred public unease and speculation online. While experts say the condition, known as cottontail rabbit papillomavirus (CRPV), is not currently transmissible to humans, some epidemiologists are warning that close monitoring is essential to guard against any future spillover. The disease, spread by biting insects such as mosquitoes and fleas, causes grotesque, wart-like tumors on infected rabbits. In recent days, residents across Northern Colorado have reported seeing the animals in alarming numbers, sometimes with growths obstructing their vision or mouths. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Although CRPV has been documented for decades and is considered largely benign in wild rabbit populations, veterinary virologists note that papillomaviruses have a history of evolving. In rare cases, similar animal viruses have jumped species barriers, raising questions about whether climate change, urban expansion, and surging insect populations could create conditions for mutation. Possible impacts on domestic animals The virus is more dangerous for domesticated rabbits, where it can cause malignant tumors. Pet owners are advised to keep rabbits indoors if infected wildlife are present nearby and to seek veterinary care immediately if symptoms appear. Live Events There is currently no vaccine or treatment for CRPV, either for wild or domestic rabbits. Colorado wildlife officials stress that the public should avoid touching, feeding, or attempting to capture the infected animals. For now, the official message remains clear to keep your distance, protect your pets, and let scientists do their work. FAQs What is the horned rabbit virus ? The horned rabbit virus, formally known as cottontail rabbit papillomavirus (CRPV), is a wildlife disease that causes wart-like or horn-like growths on rabbits' heads and faces. Can the horned rabbit virus infect humans? Currently, there is no evidence that CRPV can infect humans or most household pets. Scientists say it is species-specific, but they continue to monitor for potential mutations. How does the virus spread? CRPV spreads mainly through biting insects such as mosquitoes, fleas, and ticks, making infections more common in warmer months.
